Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses

By sjmartinez • June 5, 2023

Diwanji R, O'Brien NA, Choi JE, Nguyen B, Laszewski T, Grauel AL, Yan Z, Xu X, Wu J, Ruddy DA, Piquet M, Pelletier MR, Savchenko A, Charette L, Rodrik-Outmezguine V, Baum J, Millholland JM, Wong CC, Martin AM, Dranoff G, Pruteanu-Malinici I, Cremasco V, Sabatos-Peyton C, Jayaraman P. Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses. Cancer Immunol Res. 2023 Jun 2;11(6):777-791. doi: 10.1158/2326-6066.CIR-22-0290. PMID: 37040466.

Tags: Hematology/Oncology, Publications

Impact of timing of pregnancy and genetic risk on local therapy choices for young women with breast cancer

Lipsyc-Sharf M, Huang M, Huang SY, Suresh YK, Doll A, Baker JL, Kapoor NS. Impact of timing of pregnancy and genetic risk on local therapy[...]

A Multi-Enzyme Nanocascade to Target Disease-Relevant Metabolites

Cao Z, Ren J, Yang A, Wang Z, Love M, Chen W, Yuan X, Guo X, Chen I, Lu Y, Wen J. A Multi-Enzyme Nanocascade[...]

Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma to Histiocytic/Dendritic Cell Sarcoma

Cai J, Fernandez-Hazoury D, Yoshikawa G, Minja A, Huang H, Hwang A, Qing X. Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma to Histiocytic/Dendritic Cell Sarcoma.[...]